Cornea/External Disease News

Okyo Pharma has submitted an investigational new drug application to the FDA for OK-101 for the treatment of dry eye disease.

AZR-MD-001 ophthalmic ointment showed positive 3-month safety and efficacy results for the treatment of meibomian gland dysfunction, according to a press release from Azura Ophthalmics.

Last month, I set out to discover what is in the cosmetics used around the eye that contributes to worsening dry eye disease.

I continue to follow the COVID-19 statistics on the Worldometer website.

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.

The success of ocular surgery, especially refractive surgery, hinges on the health of the ocular surface.

A 54-year-old man was referred in late 2014 for a consultation for corneal transplant surgery in the left eye.

NEW YORK — In this Healio Video Perspective from OSN New York, John A. Hovanesian, MD, FACS, discusses the IC-8 Apthera IOL from AcuFocus, designed to correct up to 1.5 D of astigmatism.

NEW YORK — In a Healio Video Perspective from OSN New York, Aziz Mottiwala, of Tarsus Pharmaceuticals, discusses the FDA acceptance of the new drug application for TP-03 for the treatment of Demodex blepharitis.

The incidence of ocular trauma in pediatric patients may be higher than previously reported, according to a study presented at Real World Ophthalmology.